Ubs Group Ag Alector, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Alector, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 116,952 shares of ALEC stock, worth $475,994. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,952

Previous 105,685 10.66%

Holding current value

$475,994

Previous $479,000 13.99%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.34 - $6.58 $48,898 - $74,136	11,267 Added 10.66%	116,952 $546,000
Q2 2024 Aug 13, 2024	SELL	$4.19 - $6.23 $518,726 - $771,280	-123,801 Reduced 53.95%	105,685 $479,000
Q1 2024 May 13, 2024	BUY	$5.69 - $8.08 $289,017 - $410,415	50,794 Added 28.43%	229,486 $1.38 Million
Q4 2023 Feb 09, 2024	BUY	$3.77 - $8.39 $373,267 - $830,693	99,010 Added 124.26%	178,692 $1.43 Million
Q3 2023 Nov 09, 2023	SELL	$5.2 - $8.77 $59,066 - $99,618	-11,359 Reduced 12.48%	79,682 $516,000
Q2 2023 Aug 11, 2023	SELL	$5.86 - $7.93 $125,234 - $169,472	-21,371 Reduced 19.01%	91,041 $547,000
Q1 2023 May 12, 2023	SELL	$5.85 - $9.84 $325,751 - $547,930	-55,684 Reduced 33.13%	112,412 $695,000
Q4 2022 Feb 08, 2023	BUY	$6.88 - $9.55 $910,829 - $1.26 Million	132,388 Added 370.75%	168,096 $1.55 Million
Q3 2022 Nov 10, 2022	SELL	$8.19 - $13.2 $380,835 - $613,800	-46,500 Reduced 56.56%	35,708 $338,000
Q2 2022 Aug 10, 2022	SELL	$7.65 - $14.24 $1.07 Million - $1.99 Million	-139,580 Reduced 62.93%	82,208 $835,000
Q1 2022 May 16, 2022	BUY	$13.02 - $20.78 $708,782 - $1.13 Million	54,438 Added 32.53%	221,788 $3.16 Million
Q4 2021 Feb 14, 2022	BUY	$19.35 - $25.54 $505,015 - $666,568	26,099 Added 18.48%	167,350 $3.46 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $2.73 Million - $4.98 Million	126,018 Added 827.27%	141,251 $3.22 Million
Q2 2021 Aug 13, 2021	SELL	$15.5 - $22.48 $730,515 - $1.06 Million	-47,130 Reduced 75.57%	15,233 $318,000
Q1 2021 May 12, 2021	BUY	$14.84 - $22.23 $819,895 - $1.23 Million	55,249 Added 776.62%	62,363 $1.26 Million
Q4 2020 Feb 11, 2021	SELL	$9.4 - $16.7 $3,628 - $6,446	-386 Reduced 5.15%	7,114 $108,000
Q3 2020 Nov 12, 2020	SELL	$10.54 - $24.96 $1,275 - $3,020	-121 Reduced 1.59%	7,500 $79,000
Q2 2020 Jul 31, 2020	SELL	$21.87 - $33.11 $103,969 - $157,404	-4,754 Reduced 38.42%	7,621 $186,000
Q1 2020 May 01, 2020	SELL	$16.25 - $35.28 $226,476 - $491,697	-13,937 Reduced 52.97%	12,375 $298,000
Q4 2019 Feb 14, 2020	SELL	$14.17 - $20.3 $55,659 - $79,738	-3,928 Reduced 12.99%	26,312 $454,000
Q3 2019 Nov 14, 2019	BUY	$14.42 - $22.2 $377,804 - $581,640	26,200 Added 648.51%	30,240 $436,000
Q2 2019 Aug 14, 2019	BUY	$16.26 - $26.42 $39,674 - $64,464	2,440 Added 152.5%	4,040 $77,000
Q1 2019 May 14, 2019	BUY	$15.97 - $22.5 $25,552 - $36,000	1,600 New	1,600 $30,000

Others Institutions Holding ALEC

# of Institutions

167

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $336M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account